Search for Clinical Trial Results

Sponsored By

Congenital Adrenal Hyperplasia - 2 Studies Found

Status Study
NOT_YET_RECRUITING Study Name: Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia
Condition:
Date: 2025-04-30
Interventions: CRN04894 is an orally active nonpeptide melanocortin 2 receptor (MC2R) or adrenocorticotropic hormone (ACTH) antagonist.
COMPLETED Study Name: A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])
Condition: Congenital Adrenal Hyperplasia
Date: 2025-04-30
Interventions: No intervention given